Miquel Ribera Pibernat, Santiago Alfonso Zamora, Maria del Mar Ballester Torrens, Sandra Ros Abarca, Francisca Moreno Fernández, Elena Violeta Iborra
{"title":"Adherencia al tratamiento tópico en pacientes con psoriasis en España: resultados de una encuesta nacional","authors":"Miquel Ribera Pibernat, Santiago Alfonso Zamora, Maria del Mar Ballester Torrens, Sandra Ros Abarca, Francisca Moreno Fernández, Elena Violeta Iborra","doi":"10.1016/j.piel.2026.06.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Adherence to topical treatment for psoriasis is a key determinant of therapeutic effectiveness in real-world clinical practice. However, it is often suboptimal and influenced by multiple patient- and treatment-related factors. The aim of this study was to analyze adherence, perceptions, and needs associated with topical treatment in patients with psoriasis in Spain.</div></div><div><h3>Material and method</h3><div>An observational, descriptive, cross-sectional study was conducted based on a survey of adult patients living in Spain (<em>n</em> = 963). Information was collected on treatment habits and adherence, evaluation of topical treatment, and disease monitoring. Adherence was assessed using two variables: compliance with medical instructions and frequency of missed applications. A comparative analysis of adherence was performed according to age, perceived improvement, number of topical treatments used, receipt of specific information, and fear of corticosteroid use.</div></div><div><h3>Results</h3><div>A total of 73.9% of patients reported applying topical treatment for psoriasis according to medical instructions, and 53.9% stated they never or almost never forgot to apply it. Additionally, 43.5% acknowledged discontinuing treatment when they felt well. Clinical improvement since treatment initiation was reported by 46.0% of participants. Dissatisfaction with treatment outcomes and certain cosmetic characteristics were the most common barriers to adherence. Furthermore, 52.3% of respondents expressed fear of topical corticosteroids, and 74.9% had not participated in choosing the treatment texture. Adherence was higher among patients over 60 years of age, those who perceived improvement with topical treatment, and those who had received specific information about its application.</div></div><div><h3>Conclusions</h3><div>Adherence to topical treatment for psoriasis remains a significant clinical challenge. There are discrepancies between self-perceived adherence and certain patterns of use. Strengthening communication between healthcare professionals and patients, improving therapeutic education, and promoting shared decision-making may help optimize adherence and, consequently, improve clinical outcomes.</div></div>","PeriodicalId":20182,"journal":{"name":"Piel","volume":"41 8","pages":"Pages 697-707"},"PeriodicalIF":0.0000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Piel","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213925126002984","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/6 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Adherence to topical treatment for psoriasis is a key determinant of therapeutic effectiveness in real-world clinical practice. However, it is often suboptimal and influenced by multiple patient- and treatment-related factors. The aim of this study was to analyze adherence, perceptions, and needs associated with topical treatment in patients with psoriasis in Spain.
Material and method
An observational, descriptive, cross-sectional study was conducted based on a survey of adult patients living in Spain (n = 963). Information was collected on treatment habits and adherence, evaluation of topical treatment, and disease monitoring. Adherence was assessed using two variables: compliance with medical instructions and frequency of missed applications. A comparative analysis of adherence was performed according to age, perceived improvement, number of topical treatments used, receipt of specific information, and fear of corticosteroid use.
Results
A total of 73.9% of patients reported applying topical treatment for psoriasis according to medical instructions, and 53.9% stated they never or almost never forgot to apply it. Additionally, 43.5% acknowledged discontinuing treatment when they felt well. Clinical improvement since treatment initiation was reported by 46.0% of participants. Dissatisfaction with treatment outcomes and certain cosmetic characteristics were the most common barriers to adherence. Furthermore, 52.3% of respondents expressed fear of topical corticosteroids, and 74.9% had not participated in choosing the treatment texture. Adherence was higher among patients over 60 years of age, those who perceived improvement with topical treatment, and those who had received specific information about its application.
Conclusions
Adherence to topical treatment for psoriasis remains a significant clinical challenge. There are discrepancies between self-perceived adherence and certain patterns of use. Strengthening communication between healthcare professionals and patients, improving therapeutic education, and promoting shared decision-making may help optimize adherence and, consequently, improve clinical outcomes.
期刊介绍:
La mejor revista para incrementar eficazmente sus habilidades diagnósticas y clínicas en dermatología, por la alta calidad de sus imágenes e iconografías, por el prestigio de sus colaboradores y por la actualidad de sus temas. Una publicación de máxima utilidad práctica para Especialistas y Profesionales de Atención Primaria.